Home > Media & Technology > Testing > AI Testing, Inspection and Certification (TIC) Services in Healthcare Market
AI TIC Services in Healthcare Market was valued at USD 1.8 billion in 2023 and is estimated to register a CAGR of over 15% between 2024 and 2032. The growth of the market can be attributed to the growing adoption of digital health solutions such telemedicine, wearable devices, and health information systems. These solutions require accurate testing and certification to ensure their reliability, security, and compliance with healthcare standards.
For instance, in February 2024, a group of 14 healthcare and consumer trade associations including the American Telemedicine Association (ATA), American Medical Association (AMA), AARP, AHIP, the Consumer Technology Association, the Digital Medicine Society, the National Committee for Quality Assurance, and the Digital Therapeutics Alliance formed the Digital Health Collaborative to speed up digital health research and adoption. The collaboration supports evidence-based research and programs to increase awareness and confidence in adopting digital health technologies.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
AI TIC Services in Healthcare Market Size in 2023: | USD 1.8 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 15% |
2024 – 2032 Value Projection: | USD 6.3 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 300 |
Tables, Charts & Figures: | 350 |
Segments covered: | Service, Type, Application |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The healthcare industry is highly regulated, with stringent standards and regulations governing the development, deployment, and use of medical devices, digital health solutions, and AI algorithms. As AI continues to revolutionize healthcare with applications in diagnostics, personalized medicine, drug discovery, and patient management, the need for specialized TIC services to validate AI algorithms and systems has become important. TIC services ensure that AI technologies are accurate, reliable, and safe for clinical use, which is essential for getting regulatory approval and gaining trust from healthcare providers.
Developing and implementing AI TIC services requires high upfront investment in technology, talent, and infrastructure. Also, the return on investment (ROI) can be uncertain, especially in the early stages of adoption. High initial costs and unclear ROI can discourage healthcare organizations from adopting AI TIC services. Ensuring these services demonstrate clear and measurable benefits is crucial for widespread adoption and market growth. Furthermore, the complex regulatory environment poses a significant challenge for TIC providers across the globe.